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Adolescence is an important period for cognitive maturation and emotional regulation and this age 23 
group is particularly vulnerable to developing depression. Diets rich in fruits and vegetables have 24 
been associated with decreased risk of developing depressive disorders across the lifespan, an 25 
association that may be due to the high flavonoid content of these foods.  Previously we have 26 
shown increases in transient positive affect in both children and young adults two hours after 27 
administration of a wild blueberry intervention. Here, using a randomized double-blind, placebo-28 
controlled trial, we investigated the effects of four weeks, daily wild blueberry supplementation 29 
(containing ~253mg anthocyanins) on transient and chronic mood in adolescents. Healthy 12-17-30 
year old (N = 64, 35 females) were recruited and randomly assigned to receive either a wild 31 
blueberry or matched placebo supplementation. Depression and anxiety symptoms were assessed 32 
before and after the intervention period using the Mood and Feelings Questionnaire and Revised 33 
Child Anxiety and Depression Scale. Transient affect was assessed before, two weeks, and at four 34 
weeks using the Positive and Negative Affect Schedule. Following the intervention period there 35 
were significantly fewer self-reported depression symptoms in participants who were supplemented 36 
with the wild blueberry intervention compared to those who received the matched placebo (p=0.02, 37 
95% CI -6.71 to -5.35). There was no between group effect on anxiety symptoms or on transient 38 
affect. Further investigation is required to identify specific mechanisms that link flavonoids 39 
consumption and mood. If replicated, the observed effects of wild blueberry supplementation may 40 
be a potential prevention strategy for adolescent depression and may have benefits for public mental 41 
health. 42 
 43 






Puberty is a complex biologically driven process that has an impact on emotional and behavioral 46 
wellbeing, resulting in a period with increased risk of developing emotional disorders and risk-47 
taking behavior. The brain undergoes cognitive maturation via synaptic remodeling well into the 48 
20s. The limbic system, responsible for governing reward processing, appetite and pleasure seeking, 49 
matures before the prefrontal cortex, which is responsible for executive functioning such as 50 
problem solving, planning, emotional regulation and multitasking. This difference in cortical 51 
maturity is hypothesized to create a developmental imbalance, making teens vulnerable to 52 
behavioral and mental health problems, such as depression (1).  53 
 54 
An episode of major depressive disorder (MDD) during adolescence is a major personal and public 55 
health problem across the world (2). The disorder has many acute and long-term adverse 56 
consequences on adolescents’ education and occupational success, relationships and family life and 57 
on their future physical and mental health (3). Each year around 7.5% of adolescents aged 13 to 18 58 
years’ experience an episode of MDD (4-6). Symptoms of MDD are distressing and include sleep and 59 
cognitive problems, low mood, irritability, feelings of worthlessness and lack of pleasure (7). Sub-60 
clinical MDD is even more common:  recent surveys in the UK suggest that ~25% of young people 61 
report elevated symptoms of depression in any given year (4,8), including depressive symptoms that 62 
are not sufficient in number or severe enough to meet diagnostic criteria. Sub-clinical symptoms 63 
have a major impact on daily functioning and are associated with increased risk of developing the 64 
disorder (4).  65 
 66 
Treatment for MDD in this age group includes psychological therapies and anti-depressant 67 
medication; however, these are only moderately effective and are often inaccessible to young 68 
people due to limited public health service resources (8).  A recent meta-analysis of psychological 69 
treatments for children and young people with mental health problems found that the effect size of 70 
treatment for depression was small (d = 0.29) and was lower than effects of treatment for other 71 
common mental health problems (9).  Many young people with MDD do not receive an evidence-72 
based treatment and the prevention of adolescent depression is, therefore, a highly valued goal (10).  73 
One potential way to prevent the onset of MDD and sub-clinical depression is through diet. Diet 74 
and depression symptoms are significantly associated in adults, although this relationship is 75 
complex and potentially bidirectional, i.e. unhealthy diet leading to low mood and vice versa (11). A 76 
recent systematic review of the association between depression symptoms and diet in adolescents 77 





depression symptoms; whilst ‘unhealthy’ diets (i.e. consumption of junk foods and saturated fats) 79 
were associated with higher depression symptoms (12). A large well-controlled epidemiological 80 
study examining associations between habitual intakes of dietary flavonoids and depression risk 81 
showed that individuals consuming diets higher in flavonoids presented a lower depression risk, 82 
particularly amongst older women (13). A similar study assessed symptoms of depression and the 83 
total habitual intake of polyphenols among the participants and found that higher dietary intake of 84 
flavonoids was inversely associated with depressive symptoms (14). Thus, diets rich in fruits and 85 
vegetables are associated with low depression symptoms. Dietary flavonoids are present in 86 
substantial concentrations in commonly consumed fruits and vegetables and may be a potential 87 
mediator for the anti-depressant action of diets rich in fruits and vegetables.  88 
 89 
The hypothesis that there is a causal relationship between diet and depression symptoms and the 90 
onset of MDD has recently been strengthened by number of intervention studies. Acute purple 91 
grape juice intervention resulted in increase in self-reported ratings of ‘calm’ in healthy young 92 
adults (15). Similarly, acute consumption of flavonoid-rich wild blueberry improved short-term 93 
positive mood in children aged 7-10 years and in young adults aged 18-25 years (16). In a recent 94 
randomized controlled trial with 67 depressed adults (17), participants randomized to an intervention 95 
promoting a healthy diet with at least nine portions of fruit and vegetables each day reported 96 
significantly less depression symptoms at twelve weeks than those randomized to receive social 97 
support. Anti-depressive effects of flavonoid rich plants and their extracts have also been 98 
investigated. Hypercium perforatum (also known as Saint John’s wort, derived from a flowering 99 
plant in the Hypericaceae family) extract intervention studies show its effectiveness as treatment for 100 
mild/moderate depression when compared to placebo and have similar effects to pharmacological 101 
treatments (18-21). Similarly, saffron (Crocus sativus, derived from the saffron spice of the flowering 102 
plant of Crocus genus) extract consumption had equivalent effect as pharmacological treatment for 103 
depression and was significantly more effective than the matched placebo (22-24). 104 
 105 
The specific effects of sustained wild blueberry flavonoid consumption on symptoms of depression 106 
in adolescents have not yet been tested. Here, we designed a double-blind, placebo-controlled 107 
experiment to test the effect of consuming a flavonoid-rich wild blueberry intervention for four 108 
weeks on symptoms of depression, anxiety and transient affect in healthy adolescents.  Participants 109 
were randomly assigned to a wild blueberry or a matched placebo drink with transient affect and 110 









This research was reviewed and given a favorable ethical opinion for conduct by the University of 116 
Reading Research Ethics Committee (UREC 16/55). The study was registered at clinicaltrials.gov 117 
NCT03119597. 118 
  119 
Participants 120 
An a priori power analysis (using G Power 3.1.9.2) based on data from a previous study (16) 121 
revealed that 24 participants per group were required to achieve power of 0.8 with alpha set at 0.5 122 
level. Students aged 11-17 years of varying ethnicity, from four schools in Reading Berkshire, UK 123 
were invited to take part in this study. All parents or legal guardians provided informed written 124 
consent for young people under the age of 16. Participants under the age of 16 provided written 125 
assent and those over 16 gave written consent. All participants were screened for any health 126 
conditions (including mental health), any treatment they were receiving and food related allergies 127 
that would exclude them from the study. We screened 82 young people, of whom 18 dropped out 128 
after the first screening session. Sixty four participants were randomly assigned to either a wild 129 
blueberry drink or a matched placebo drink. The randomized allocation of participants to treatment 130 
was generated using excel. The groups were coded A and B and the sequence was saved in a 131 
password protected spreadsheet.  Both the researchers and the participant were blind to treatment 132 
group and participants were told the study was investigating effects of different fruit drinks so were 133 
not aware of the study hypothesis. 134 
 135 
Interventions 136 
Both interventions (wild blueberry and placebo) were measured and packaged into silver opaque 137 
sachets at the University of Reading. Sachets were identical for the wild blueberry and the placebo 138 
drink and neither the researchers nor the participants knew what their sachets contained. Wild 139 
Blueberry Association of North America provided the blueberry powder whilst the matched sugars 140 
and vitamin C (placebo) was obtained from Bulk Powders. The packets of wild blueberry contained 141 
13g of freeze-dried wild blueberry (WBB) powder (containing ~253mg anthocyanins).  Placebo 142 
packets were matched to the WBB for sugars (4.52g glucose and 4.79g fructose) and vitamin C (4 143 
mg). Each participant was given 14 days’ supply of their requisite intervention, along with written 144 
and video instructions for their parents/guardians on how to prepare the intervention. Each 145 





Squash’ and 170 ml of water and the contents of the sachet to the opaque cup provided. Each 147 
participant was given a checklist to record the dates and times when they consumed the drink each 148 
day and the name of the person who prepared the drinks. Participants were also asked to bring back 149 
their used sachets after two weeks as a measure of compliance. The remaining 14 days’ supply of 150 
each intervention was given to the participants two weeks into the intervention period. The true aim 151 
of the study was not disclosed to the participants, they were informed that it was a fruit drink study, 152 
to avoid revealing the contents of the drink. 153 
 154 
Measures 155 
The Mood and Feelings Questionnaire (MFQ) was used to measure symptoms of depression (25).  156 
The MFQ is considered to be the gold standard self-report measure for depression in young people 157 
(NICE, 2015).  It is a standardized and well-validated 33-item self-report measure of the severity of 158 
depression symptoms in adolescents. Each item relates to a symptom or experience associated with 159 
depression.   Participants are asked to rate each item in relation to their symptoms in the past 2 160 
weeks on a 3-point Likert scale (not true = 0, sometimes = 1, true = 2). Total MFQ scores range 161 
from 0 to 66 where higher scores indicate greater risk of depression.  The clinical cut off for the 162 
MFQ is 27, with scores above 27 indicating significant risk of a diagnosis of MDD (25). 163 
 164 
Anxiety symptoms were assessed using the anxiety sub-scale of the Revised Child Anxiety and 165 
Depression Scale (RCADS) (26), a standardized and validated measure of anxiety symptoms in 166 
young people used routinely in UK NHS mental health services.  The anxiety sub-scale of RCADS 167 
consists of 37 items, each rated on a 4-point Likert scale (never =1, sometimes = 2, often = 3, 168 
always = 4).  Total scores range from 37 to 148 with higher scores indicating increased risk of an 169 
anxiety disorder. Again, participants were asked to rate the items keeping the past two weeks in 170 
mind.  171 
 172 
Current mood (i.e. transient affect) was assessed using the Positive and Negative Affect Schedule-173 
NOW (PANAS-NOW) at screening, and at two and four weeks. As the term suggests this is a 174 
measure of transient mood. The PANAS is a valid and reliable 20 self-report measure of positive 175 
affect (PA – 10 items) and negative affect (NA - 10 items) that can be used on multiple test 176 
occasions (27,28). Participants rated the degree to which they were currently experiencing each item 177 
on a 5-point Likert scale ranging from ‘very slightly’ to ‘extremely’.  Ratings of positive and 178 
negative items were summed to calculate an overall positive affect and overall negative affect score, 179 






Habitual fruit and vegetable consumption were assessed using EPIC-Norfolk food frequency 182 
questionnaire, a semi-quantitative paper-based questionnaire, which includes 130 food items, each 183 
rated on 9-point Likert scale (never or less than a month-1 to 6+perday-9). FETA software was used 184 
to analyse the data collected to calculate 46 nutrient and 14 food group values including average 185 
daily fruit and vegetable intake (29).  186 
 187 
Other measures i.e. working memory, verbal fluency, cognitive accuracy and reaction time were 188 




As outlined in Figure 1, participants were seen by the researchers four times across a five weeks 193 
period. All participants did not attend all assessment – the number of participants assessed at each 194 
timepoint is indicated in Figure 1. Research sessions took place either at the University of Reading 195 
or at the participant’s school.  Sessions were scheduled at the same time of day for each participant.  196 
The first two sessions, scheduled 48 hours apart, were screening sessions where participants 197 
completed a battery of questionnaires: MFQ, RCADS, (screening session 1) PANAS, EPIC- 198 
Norfolk food frequency questionnaire and a questionnaire about their health status (screening 199 
session 2). Screening sessions were limited to 30 minutes to fit with the school timetable and to 200 
maintain high levels of participant engagement in both sessions.  Parents were also asked to 201 
complete a demographic questionnaire.  Participants started the intervention the day after the 202 
second screening session was completed. Two weeks later they returned their used drink sachets, 203 
were given a new checklist and completed the PANAS (Test session 1). Participants were also 204 
asked if they were experiencing any adverse effects of the drink and feedback on its palatability.  205 
They then returned two weeks later (Test session 2), returned their drink sachets, completed the 206 
PANAS, MFQ and RCADS and were debriefed. For each test session, participants were instructed 207 
not to consume their allocated intervention before the test session to ensure that chronic, not acute, 208 
effects of the intervention were being measured. 209 
 210 
Statistical Analysis 211 
Statistical analyses were conducted using IMB SPSS version 22. T-test was used to investigate 212 
differences in symptoms of depression, anxiety and fruit and vegetable intake between the two 213 





Modelling (LMM) using an unstructured covariance matrix to model successive repeat test sessions, 215 
with subjects included as random effects. Data from two weeks and four weeks measures of the 216 
PANAS and treatment group were included as fixed factors, with baseline PANAS scores included 217 
as a covariate. LMM deals with data that is missing at random and with multiple measurement 218 
points, giving unbiased estimates of each of the means. To test the effects of the intervention on 219 
anxiety and depressive symptoms at four weeks, data were analysed using Analysis of Covariance 220 
(ANCOVA) with drink (Placebo, WBB) as an independent variable and MFQ and RCADS scores 221 
at 4 weeks as dependent variable. Baseline measures of depression and anxiety were used as 222 
covariates and Bonferroni corrected t-tests were used to investigate all fixed effects and 223 
interactions.  224 
 225 
Results  226 
Sample characteristics  227 
Sixty-four participants were randomised (35 females, 29 males) aged 12-17 years (M = 14.20 years, 228 
SD = 1.71).  Thirty-five participants were randomly allocated to receive the placebo drink and 229 
twenty-nine to the WBB intervention. Participants’ demographic data, baseline mood scores and 230 
habitual fruit and vegetable intakes are reported in table 1. There were no significant differences 231 
between groups in the amount of daily fruit t (51) = 0.14, p = 0.89 or vegetables t (51) = 1.45, p = 232 
0.15 consumed. One sample t-test revealed that the mean fruit and vegetable consumption by the 233 
participants was significantly lower than the 400g per day as recommended by WHO; fruit: t (52) = 234 
11.20,  p<0.005, vegetables t (52) = 7.12  p< 0.005). 235 
 236 
At baseline mean depression and anxiety scores were 12.35 (SD = 9.31) and 23.19 (SD = 13.80) 237 
respectively, both below the clinical threshold. There was no significant group difference in 238 
symptoms at baseline; MFQ t (60) = 0.60, p = 0.55,  RCADS t (40) = 0.45, p=0.66 and no group 239 
difference in mean positive and negative affect; t (62) = 1.40, p=0.17 and t (62) =0.80, p=0.98 240 
respectively.  A minority of participants (9.38%) reported depression symptoms above the clinical 241 
cut-off of 27 on the MFQ (11.4% in the placebo group, 3.4% in the intervention group). No 242 
participants reported anxiety symptoms above the clinical threshold. No participants reported a 243 
diagnosis of depression or anxiety, or that they were receiving treatment for these disorders.  244 
 245 
Hypothesis testing 246 
At four weeks 59 participants provided self-report data on anxiety (RCADS) and depression (MFQ) 247 





after four weeks of the intervention, the mean MFQ score for participants who consumed WBB was 249 
significantly lower than the mean MFQ score for participants who consumed the placebo drink.  250 
This was significant F(1,57)=5.52, p=0.02 95%CI -6.71 to -5.35 with a medium effect size (d = 0. 251 
65). The change in the depression scores for each participant including regression line for both 252 
treatments is shown in figure 3. There was no significant effect of WBB on symptoms of anxiety 253 
(Figure 2b) after four weeks of supplementation F (1,34) = 2.1,  p=0.16; mean RCADS score for 254 
participants in the WBB group was 13.90, (SD = 8.39) and the mean RCADS for the placebo group 255 
was 19.3, (SD = 11.31).   256 
 257 
We also examined the effect of intervention on positive affect and negative affect (PANAS) after 258 
two and four weeks (see Figure 4). There was no significant effect of Drink, F (1,64.33) = 0.26, 259 
p=0.62, Repeated trial, F( 1,62.22) = 2.95, p=0.09,  or any Drink x Repeated trial interaction F 260 
(1,62.22) = 3.686, p=0.06 on transient positive affect. Figure 4a shows the mean PA scores 261 
following intervention of WBB and placebo at two weeks and at four weeks. There was also no 262 
significant effect of the intervention on NA; Repeated trial, F(1,59.3) = 0.66 p=0.42, Drink, F 263 
(1,63.79) = 0.24 p=0.63 or Repeated trial × Drink interaction, F(1,59.30) =1.17, p=0.28. As shown 264 




This randomized, placebo controlled, double blinded trial investigated the effects of 4 weeks 269 
consumption of a flavonoid-rich WBB drink on symptoms of depression and anxiety and on 270 
transient affect in a community sample of healthy 12-17-year old.  The results demonstrated that 271 
after four weeks of daily WBB intervention there was a between groups difference in self-reported 272 
depressive symptoms; participants randomised to the WBB intervention reported significantly 273 
lower scores on the measure of depression symptoms than participants who were randomised to the 274 
placebo drink.  There was no significant effect of the intervention on anxiety symptoms or on 275 
positive affect or negative affect (i.e. transient affect). The data suggest that flavonoid 276 
supplementation may be beneficial in reducing depressive symptoms in healthy adolescents.  277 
 278 
This is, to our knowledge, the first randomized double blinded study to show the effects of chronic 279 
WBB flavonoids on depression symptoms in teenagers. The participants in the study were healthy 280 
but at baseline assessment were consuming sub-optimal habitual levels of flavonoids, i.e. their daily 281 





amount of 400g/day (31,32). This is consistent with the typical diet of young people in the UK, where 283 
only 18% of adolescents meet the recommended daily requirement, and the average daily 284 
consumption within this age group is 256g (3.5 portions) of fruit and vegetables (33).  Levels of 285 
depression and anxiety were similar to community norms on gold standard self-report measures. 286 
Importantly, because the effects of the intervention were observed in a community sample, these 287 
effects cannot necessarily be generalised to adolescents with more severe symptoms of depression 288 
or a diagnosis of depression.  289 
 290 
Within this community sample the effect size of the flavonoid intervention compared to the control 291 
group on the measure of depression symptoms, the MFQ, was d = 0.65, a medium effect size.  To 292 
put this into context, two recent meta-analyses have examined the effects of psychological 293 
treatments for depression and the prevention of depression. Ecksthtain et al., (2019) concluded that 294 
the treatment effect size of psychological treatments for adolescents with depression was d = .36 295 
(34).  In a review of interventions to prevent depression Ssegonia et al., (2019) reported an effect size 296 
of d = .22 (35).  In relation to the specific measure of depression used in this study the reduction of 297 
the 4 points on mean MFQ scores in the intervention group indicates complete amelioration of 2 298 
items on the scale or a reduction (from 2 to 1, or 1 to 0) of 4 items. Because each item reflects a 299 
symptom or adverse effect of depression, clinically this would be likely to reflect a meaningful 300 
reduction in the impact of depression on the young person (36).  301 
 302 
Previously the effects of flavonoids from different sources such as apples, cocoa and grape juice 303 
showed no effects on depression in healthy adults (37-40).  However, our results are consistent with 304 
previous animal and epidemiological studies that suggest anti-depressive effects of a flavonoid rich 305 
diet (13,41-44).They also are in keeping with experimental data on the acute effects of WBB on 306 
positive mood in children and young adults (15,16), and the acute effect of grape juice on mood in 307 
healthy adults (45). Unlike a previous acute intervention study, we did not observe a significant 308 
effect of WBB on momentary mood (i.e. transitory affect). However, the interval between 309 
consuming the WBB drink and assessing NA and PA was variable, unlike the standard 2-hour 310 
interval used in previous studies.  In addition, the four-week assessment (our end point) was 311 
conducted during the first week of school after the summer holidays. Unlike symptoms of 312 
depression (and anxiety) which were measured over a minimum two-week period and which are 313 
conceptualised as relatively stable, positive and negative affect are conceived as short-lived events 314 
that have rapid decay after elicitation (46). It is therefore possible that this external event (returning 315 






Although anxiety and depression are frequently co-morbid in young people and share some 318 
symptoms (e.g. fatigue, low concentration and sleep disturbances), the results of this intervention 319 
study suggest that flavonoids may reduce symptoms that are more prominent in depression than 320 
anxiety, e.g. low mood, anhedonia, feelings of guilt, and worthlessness and do not reduce symptoms 321 
that are specific to anxiety.  However, it is also possible that the effect of flavonoids on anxiety is 322 
smaller than the effect on depression and that a larger sample, with greater power, might result in a 323 
significant effect.  324 
 325 
Some authors have proposed that flavonoids increase cerebral blood flow to the dorsolateral 326 
prefrontal cortex, a site that is highly associated with cognitive and emotional regulation, including 327 
rumination, a cognitive process of repetitive thinking that may exacerbate feelings of guilt and 328 
worthlessness (47-49). This suggests that there may be an indirect pathway between flavonoid 329 
consumption and depression whereby flavonoid consumption enhance cerebral blood flow, which 330 
boosts executive functioning; in turn improved executive functioning helps to enhance cognitive 331 
control, inhibits rumination and thus reduces depression.  Adolescents with depression have 332 
impaired executive function compared to non-depressed and anxious young people (50) and therefore 333 
the benefits of flavonoid consumption may be more prominent in these young people. However, 334 
potentially any positive effects of flavonoid consumption on executive function would have benefits 335 
for more young people because executive function is critical for academic achievement (51).  336 
 337 
A plausible direct pathway between flavonoid consumption and mood is the effects of flavonoids 338 
on Monoamine Oxidase (MAO) (52). MAO inhibitors have been used to treat mood disorders and 339 
flavonoids may mimic their effects (52,53). A recent study showed that consuming fruits high in 340 
flavonoids i.e. blackcurrants significantly reduces MAO activity and increases the circulating 341 
monoamines and thereby elevates mood (52). Another possible mechanism by which flavonoids may 342 
affect mood is by mimicking anxiolytic-like effects by binding to benzodiazepine receptors, 343 
enhancing the effect of GABA via GABAA receptors (34,54,55). However, in line with a previous 344 
study (16) that showed no changes in negative affect (an indicator of anxiety) after acute flavonoid 345 
intervention, here there was no significant of flavonoid consumption on anxiety.  346 
 347 
Although the mechanisms of action require further investigation there is accumulating evidence of a 348 
causal relationship between flavonoid consumption and depression symptoms.  This evidence has 349 





epidemiology, clinical trials and experiments. However, the research is preliminary and requires 351 
robust replication and extension, with larger samples, longer time scales and careful tests of 352 
mechanisms of action. Our study examined the effects of flavonoids on healthy young people, some 353 
of whom had elevated symptoms of depression.  We did not have adequate power to conduct sub-354 
group analysis but clearly it is important to identify if the change in depression symptoms is driven 355 
by improvements in those with relatively elevated symptoms, or if the effects are similar across all 356 
levels of baseline depression.  This distinction is important because flavonoids may have the 357 
potential to prevent depression in those at risk (i.e. those with elevated symptoms) or may have a 358 
more general effect.  The former would suggest that dietary interventions could be used for early 359 
intervention in those exhibiting symptoms of depression; the latter that dietary interventions could 360 
have a broader benefit to public mental health.  361 
 362 
Conclusions  363 
This randomized double-blind study demonstrated the chronic effects of wild blueberry flavonoid 364 
consumption on reducing symptoms of depression in a community sample of adolescents. Dietary 365 
flavonoid interventions may have potential to reduce symptoms of depression in adolescents.  This 366 
study requires replication, not only in healthy participants, but also in clinically referred samples to 367 
assess the potential of flavonoids to be used as a practical and cost-effective intervention. In 368 
addition to this, studies focused on investigating biochemical changes and investigating the 369 
mechanistic pathways in which flavonoids decrease depressive symptoms in humans is essential. 370 
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Table 1: Demographic details, mean fruit and vegetable intake and mean depression and anxiety 535 
scores at baseline for both intervention groups. 536 
 PLACEBO GROUP WILD BLUEBERRY 
GROUP 
P VALUES 
MEAN AGE  14.5 (SD=1.804) 13.82(SD=1.54) P=0.11 
MALE % 48.6 41.4 P=0.57 
FEMALE % 51.4 58.6 P=0.57 
BRITISH % 60 52.4 P=0.52 
ASIAN% 11.4 12.5 P=0.52 
MIXED% 5.8 12.6 P=0.52 
AFRICAN 2.9 8.3 P=0.52 
CHINESE 2.9 4.2 P=0.52 
MEAN FRUIT INTAKE 
(GRAMS/DAY) 
188 (SD=168.3) 176 (SD=98.0) P=0.89 
MEAN VEGETABLES (GRAMS/DAY) 257.6 (SD= 187.0) 187.5 (SD=144.6) P=0.15 
MEAN DEPRESSION (MFQ)  13.0 (SD= 10.0) 11.3 (SD= 8.5) P=0.55 
MEAN ANXIETY (RCADS)  24.2 (SD= 14.90) 22.3 (SD=13.0) P=0.66 
MEAN POSITVE AFFECT  28.0 (SD=7.7) 25.3 (SD=8.0) P=0.17 
MEAN NEGATIVE AFFECT  15.1 (SD=5.24) 14.1 (SD=4.38) P=0.98 
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